These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17133364)

  • 1. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells.
    Ohashi N; Yaar M; Eller MS; Truzzi F; Gilchrest BA
    J Cell Physiol; 2007 Mar; 210(3):582-95. PubMed ID: 17133364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis by telomere 3' overhang-specific DNA.
    Eller MS; Puri N; Hadshiew IM; Venna SS; Gilchrest BA
    Exp Cell Res; 2002 Jun; 276(2):185-93. PubMed ID: 12027448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.
    Pitman RT; Wojdyla L; Puri N
    Oncotarget; 2013 May; 4(5):761-71. PubMed ID: 23800953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere-based DNA damage responses: a new approach to melanoma.
    Puri N; Eller MS; Byers HR; Dykstra S; Kubera J; Gilchrest BA
    FASEB J; 2004 Sep; 18(12):1373-81. PubMed ID: 15333580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.
    Yaar M; Eller MS; Panova I; Kubera J; Wee LH; Cowan KH; Gilchrest BA
    Breast Cancer Res; 2007; 9(1):R13. PubMed ID: 17257427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
    Li GZ; Eller MS; Hanna K; Gilchrest BA
    Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.
    Sarkar S; Faller DV
    Oligonucleotides; 2011 Feb; 21(1):47-53. PubMed ID: 21281128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment.
    Weng D; Cunin MC; Song B; Price BD; Eller MS; Gilchrest BA; Calderwood SK; Gong J
    Breast Cancer Res; 2010; 12(5):R71. PubMed ID: 20846433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
    Puri N; Pitman RT; Mulnix RE; Erickson T; Iness AN; Vitali C; Zhao Y; Salgia R
    Cancer Lett; 2014 Feb; 343(1):14-23. PubMed ID: 24041868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
    Aoki H; Iwado E; Eller MS; Kondo Y; Fujiwara K; Li GZ; Hess KR; Siwak DR; Sawaya R; Mills GB; Gilchrest BA; Kondo S
    FASEB J; 2007 Sep; 21(11):2918-30. PubMed ID: 17449721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.
    Eller MS; Li GZ; Firoozabadi R; Puri N; Gilchrest BA
    FASEB J; 2003 Feb; 17(2):152-62. PubMed ID: 12554694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
    Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
    J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ssDNA fragments induce cell senescence by telomere uncapping.
    Tsolou A; Passos JF; Nelson G; Arai Y; Zglinicki Tv
    Exp Gerontol; 2008 Oct; 43(10):892-9. PubMed ID: 18778766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-oligo as an anticancer agent in colorectal cancer.
    Wojdyla L; Stone AL; Sethakorn N; Uppada SB; Devito JT; Bissonnette M; Puri N
    Biochem Biophys Res Commun; 2014 Apr; 446(2):596-601. PubMed ID: 24632202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmentation and rapid shortening of telomere in HeLa cells in the early phase of hydroxyl radical-induced apoptosis.
    Shao L; Li QH; Wang J; Tan Z
    Cancer Biol Ther; 2005 Mar; 4(3):336-41. PubMed ID: 16210918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length maintenance in aging and carcinogenesis.
    Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
    Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular senescence, telomere recombination and maintenance.
    Yang Q
    Cytogenet Genome Res; 2008; 122(3-4):211-8. PubMed ID: 19188689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.